tyb
>>21540 pb
Senior Mexican ruling party lawmaker proposes delay to central bank bill
A senior lawmaker in Mexico’s ruling party on Friday urged the lower house of Congress to suspend debate until next year on a controversial financial bill that has sparked stiff resistance from the central bank as an attack on its autonomy.
Mexico’s Senate on Wednesday passed the draft legislation that would make the Bank of Mexico (Banxico) buy up cash that commercial banks cannot return to the financial system. The Senate’s approval of the law, which was pitched by President Andres Manuel Lopez Obrador’s ruling National Regeneration Movement (MORENA), met with strong pushback from the central bank due to the apparent risks it harbors. Advocates of the law say it will help poor migrant families disadvantaged by the financial system to unload their cash. But critics say it could end up forcing Banxico to absorb money from drug gangs and make it a target of international authorities.
Congressman Alfonso Ramirez Cuellar, a former head of the lower house budget committee and former party chairman of MORENA, said the bill was too important to be rushed through Congress.
To that end, Ramirez said he was proposing that debate on the bill be postponed until Congress reconvenes in February. Congress is due to enter winter recess on Dec. 15. “Congress must safeguard the Bank of Mexico’s faculties and avoid the risk of contaminating the foreign exchange system,” he wrote on Twitter, calling for national debate on the issue.
https://www.reuters.com/article/mexico-cenbank-reform/senior-mexican-ruling-party-lawmaker-proposes-delay-to-central-bank-bill-idUSL1N2IR2JC
RCH504 USAF C-17 Globey departed Manaus, Brazil after a ground stop.
Arrived at Rio Int'l yesterday from Charleston, SC-Int'l Airport.
not related to the above but interdasting and missed this on Weds
Boeing 737 Max back in air 2 years after grounded by crashes
Commercial flights with Boeing 737 Max jetliners resumed Wednesday for the first time since they were grounded worldwide nearly two years ago following two deadly accidents.
Brazil’s Gol Airlines became the first in the world to return the planes to its active fleet, using a 737 Max 8 on a flight from Sao Paulo to Porto Alegre, according to flightradar24.com. The company own announcement didn’t specify the route of the flight. Gol is set to start regular service on Dec. 18, according to aviation data firm Cirium, with several daily flights between Sao Paulo and other major Brazilian cities.
https://apnews.com/article/brazil-max-airlines-sao-paulo-porto-alegre-d7b53889375fea9fb817ac471deeccf3
it's quite funny
SAM276 USAF C-32A ne departure from JBA
This AC is used as primary AF2
SAM181 USAF G5 also out from JBA with some data spoofing just north of New York-Stewart Airport making a turn to head east for line-up at Stewart Airport (just north of West Point)
Belgian AF BAF89 Falcon 700X inbound from Brussels Int'l Airport
AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases. AstraZeneca, one of the frontrunners in the drug industry’s search for a COVID-19 vaccine, said on Saturday that Alexion shareholders would receive $60 in cash and about $115 worth of equity, either in London-traded ordinary shares or in dollar-denominated American Depositary Shares.
Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Alexion shares closed at around $121 apiece on Friday.
“This acquisition allows us to enhance our presence in immunology,” AstraZeneca Chief Executive Pascal Soriot said in a statement. “Alexion has established itself as a leader in complement biology, bringing life-changing benefits to patients with rare diseases.” The British company said the boards of both companies had approved the deal which, subject to regulatory and shareholder approval, is expected to close in the third quarter of 2021.
Alexion shares have struggled in the last few years as investors have wondered whether the company had a follow-up therapy to its best-selling franchise that treats rare diseases - a stock market performance that has made it seen as a possible takeover target.
Hedge fund Elliott Management, one of the world’s most powerful activist investors, had been urging Alexion to sell itself for months and in May spoke out publicly one day before the company’s annual shareholder meeting. The fund, which had held private meetings with the company, argued that CEO Ludwig Hantson’s “go-it-alone” approach had failed to gain traction and that its plan to buy rivals to diversify its research pipeline were leading in the wrong direction. Elliott first invested in Alexion in 2017 when the share price was only slightly lower than where it closed at $120.98 on Friday. Elliott did not immediately respond to a request for comment.
Soriot told a media call the deal was the result of exclusive talks, and no competitive bidder was involved. AstraZeneca finance chief Marc Dunoyer told the same call that a capital increase for the equity component of the transaction would take place at the closure of the deal.
On AstraZeneca’s experimental COVID-19 vaccine, being developed with Oxford University, Soriot said it wasn’t yet clear if the company would need results from a U.S. clinical trial before filing for approval with U.S. regulators.
Assuming positive results from that trial, the company should be able to submit the vaccine to U.S. regulators within the next six weeks, he added.
https://www.reuters.com/article/alexion-pharms-ma-astrazeneca/update-3-astrazeneca-to-buy-alexion-for-39-bln-to-expand-in-immunology-idUSL1N2IS083
Elliott Management is run by Paul Singer and you may recall this hedge-fund took a large stake in Twatter earlier this year.
Billionaire Republican buys major Twitter stake, may oust CEO amid GOP concerns of bias, reports say
https://www.foxnews.com/politics/twitter-paul-singer-republican-jack-dorsey
have had some of dat recently-good for the soul.